Department of Pediatrics, Pediatric Hematology and Oncology, University Clinic of the Justus-Liebig-University of Giessen, Germany
Christine Mauz-Körholz is a pediatric oncologist and an Associate Professor of Pediatrics and is head of the Pediatric Hodgkin Lymphoma Trial office in Giessen, Germany, and Scientific Secretary of the European Network for Pediatric Hodgkin Lymphoma (EuroNet-PHL) trial consortium. For more than a decade, her research has focused on conducting clinical trials for optimizing treatment and lowering treatment burden in children and adolescents with Hodgkin lymphoma. The main goal of the contemporary Hodgkin lymphoma trials is to significantly lower treatment toxicity for avoiding late effects in later life of Hodgkin lymphoma survivors, namely reduce radiotherapy burden to limit the rate of second malignancy and to eliminate gonadotoxic agents to preserve fertility in those young Hodgkin lymphoma survivors with childbearing potential. During the last couple of years, Prof.. Mauz-Körholz has launched and chaired a global platform, the International Symposia for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (ISCAYAHL) together with Prof. Monika Metzger, St Jude Children’s Research Hospital, Memphis, TN, USA. These meetings take place every three years and serve as a major forum for the Pediatric Hodgkin lymphoma community, globally. Another important initiative has been started, the “Staging-Evaluation-and Response-Criteria-Harmonisation-Initiative (SEARCH for CAYAHL). Thereby, the comparability of clinical trials not only among pediatric consortia but also between pediatric and adult trial consortia should eventually be possible; which is of tremendous value for trials with new agents. She has 86 peer-reviewed publications in international medical science journals.